BiotechTubeBiotechTube
Home/Investors/Forbion

Forbion

Biotech Investor · 4 portfolio companies

Portfolio
4
Combined Value
$4.3B
Focus Areas
13
Top Stage
Phase 3

Investment Focus

CardiovascularMetabolic DiseasesDyslipidemiaAutoimmune DiseasesImmunologyRheumatologyNeurologyNephrologyOncologyInflammatory DiseasesGenetic DisordersRespiratoryInfectious Disease

Portfolio Companies

CompanyValuation
NewAmsterdam Pharma Company$3.3B
Vor Biopharma$499.9M
enGene$483.0M
Altesa BioSciences—

Frequent Co-Investors

Medicxi2 sharedBVF Partners1 sharedRA Capital Management1 sharedFrazier Life Sciences1 sharedDeerfield Management1 sharedAscendant BioCapital1 sharedLSP1 sharedPopulation Health Partners1 shared